Assessing the Ability of the T-SPOT®.TB Test (IQ)
Completed
Conditions studied: Tuberculosis
In brief
The primary objective of this clinical research study is to demonstrate performance of the normalized TB specific lymphocyte response (NTBSLR) in identifying patients with active TB disease. The secondary exploratory objective is to demonstrate that active TB cannot be identified using an antigen-to-mitogen ratio derived from an ELISA-based IGRA.
Key facts
- Study ID
- NCT03973970
- Run by
- Oxford Immunotec
- People needed
- 201
- Starts
- 2019-09-23
- Expected to finish
- 2020-06-30
- Last updated by the study team
- 2021-02-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Texas Health — Brownsville, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.